New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

T-bet is a transcription factor, one of the control proteins in the cell nucleus that can turn specific groups of genes on ...

FEMA records show Kerr County officials did not use FEMA’s system to send warnings to phones in the critical hours as the ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Cellenkos is currently in clinical trials for various inflammatory and autoimmune diseases, including ALS, bone marrow ...

Experimental treatment could offer a safer, cheaper alternative to CAR-T-cell therapies for disorders such as lupus.

Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...

A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...